Stockscreener 앱 받기
1.96
1.55%
0.03
시간 외 거래:
1.95
-0.01
-0.51%
전일 마감가:
$1.93
열려 있는:
$1.95
하루 거래량:
3.06M
Relative Volume:
0.18
시가총액:
$248.30M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-1.1951
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-0.51%
1개월 성능:
-10.09%
6개월 성능:
+117.78%
1년 성능:
+137.58%
1일 변동 폭
$1.90
$2.02
1주일 범위
$1.90
$2.11
52주 변동 폭
$0.1311
$3.29
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
1.96 | 244.50M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
How to integrate Vor Biopharma Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Risk vs reward if holding onto Vor Biopharma Inc.Gap Up & High Accuracy Investment Signals - Newser
Is Vor Biopharma Inc. likely to announce a buybackMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Is Vor Biopharma Inc.’s growth already priced inJuly 2025 Gainers & Safe Entry Momentum Stock Tips - خودرو بانک
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million - Investing.com
What is Vor Biopharma Inc. s 5 year growth outlookInsider Buying & Fast Exit Strategy with Risk Control - خودرو بانک
How cyclical is Vor Biopharma Inc.’s revenue streamJuly 2025 Trends & Accurate Entry and Exit Point Alerts - خودرو بانک
Measuring Vor Biopharma Inc.’s beta against major indicesStop Loss & Momentum Based Trading Signals - Newser
What’s next for Vor Biopharma Inc. stock priceQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Earnings Summary Report & Long-Term Growth Plans - Newser
Can Vor Biopharma Inc. lead its sector in growthPortfolio Value Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Vor Biopharma shares rise 2.59% premarket after Connect Biopharma's Nasdaq listing. - AInvest
Is Vor Biopharma Inc. gaining market shareSwing Trade & Fast Gaining Stock Strategy Reports - خودرو بانک
Does Vor Biopharma Inc. fit your quant trading modelWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Quantitative breakdown of Vor Biopharma Inc. recent moveOptions Play & High Win Rate Trade Tips - Newser
Is Vor Biopharma Inc. stock overvalued or fairly priced2025 Major Catalysts & Weekly High Return Stock Opportunities - خودرو بانک
Custom strategy builders for tracking Vor Biopharma Inc.2025 Big Picture & Verified Entry Point Signals - Newser
What data driven models say about Vor Biopharma Inc.’s futureShare Buyback & Stock Portfolio Risk Management - Newser
Real time social sentiment graph for Vor Biopharma Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Vor Biopharma Inc. explained2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Is Vor Biopharma Inc. stock a good pick for beginnersJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - خودرو بانک
Vor Biopharma Inc. stock trend outlook and recovery pathMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Using data filters to optimize entry into Vor Biopharma Inc.July 2025 Drop Watch & Verified Technical Trade Signals - Newser
Applying chart zones and confluence areas to Vor Biopharma Inc.Bond Market & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Vor Biopharma Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Can Vor Biopharma Inc. grow without external fundingJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
What is Vor Biopharma Inc.’s book value per share2025 Big Picture & Technical Pattern Based Buy Signals - خودرو بانک
Vor Biopharma Focuses on Telitacicept Development Strategy - MSN
Can Vor Biopharma Inc. recover in the next quarterIPO Watch & Expert Curated Trade Ideas - Newser
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):